Check the publications from some of our COST Action members:

  • Targeted Fucosylation of Glycans with Engineered Bacterial Fucosyltransferase Variants, V. Křen, L. Elling et al, ChemCatChem 2022, 14, e202200037.

doi.org/10.1002/cctc.202200037

  • Methods of in vitro study of galectin-glycomaterial interaction, V. Křen, L. Elling et al, Biotechnology Advances, 2022, 58, 107928,

https://www.sciencedirect.com/science/article/abs/pii/S0734975022000246?via%3Dihub

  • Access to both anomers of rutinosyl azide using wild-type rutinosidase and its catalytic nucleophile mutant, V. Křen et al, Catalysis Communications, 2021, 149, 106193,

https://doi.org/10.1016/j.catcom.2020.106193.

  • Exploration of GH94 Sequence Space for Enzyme Discovery Reveals a Novel Glucosylgalactose Phosphorylase Specificity M. De Doncker, et al, ChemBioChem 2021, 22, 3319.

doi.org/10.1002/cbic.20210040

  • Advanced glycosidases as ingenious biosynthetic instruments, Z. Mészáros et al, Biotechnology Advances, 2021, 49, 107733,

https://www.sciencedirect.com/science/article/abs/pii/S0734975021000392?via%3Dihub

  • Design and synthesis of novel 3-triazolyl-1-thiogalactosides as galectin-1, -3 and -8 inhibitors, S. van Klaveren et al,                 RSC Adv., 2022, 12, 18973-18984

https://pubs.rsc.org/en/content/articlelanding/2022/RA/D2RA03163A

  • Discovery of a New Drug-like Series of OGT Inhibitors by Virtual Screening. EM Loi et al, Molecules, 2022, 27, 1996.

https://www.mdpi.com/1420-3049/27/6/1996/htm

  • Selective Galectin-8N Ligands: The Design and Synthesis of Phthalazinone-d-Galactals, S. van Klaveren et al, ChemMedChem 2022, 17, e202100514.

https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cmdc.202100575

  • Selective Monovalent Galectin-8 Ligands Based on 3-Lactoylgalactoside, B. Girardi et al, ChemMedChem 2022, 17, e202100514.

https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cmdc.202100514

  • Structure-Guided Design of d-Galactal Derivatives with High Affinity and Selectivity for the Galectin-8 N-Terminal Domain, M. Hassan et al, ACS Med. Chem. Lett. 2021, 12, 1745–1752

https://pubs.acs.org/doi/10.1021/acsmedchemlett.1c00371

  • Benzimidazole–galactosides bind selectively to the Galectin-8 N-Terminal domain: Structure-based design and optimisation, M. Hassan et al, European Journal of Medicinal Chemistry, 2021, 223, 113664

https://www.sciencedirect.com/science/article/pii/S0223523421005134?via%3Dihub

  • New Quinolinone O-GlcNAc Transferase Inhibitors Based on Fragment Growth, M Weiss et al, Frontiers in Chemistry, 2021, 9                                

https://www.frontiersin.org/articles/10.3389/fchem.2021.666122/full

  • Does targeting Arg98 of FimH lead to high affinity antagonists?, T Tomašič et al, European Journal of Medicinal Chemistry, 2021, 211, 113093,

https://www.sciencedirect.com/science/article/abs/pii/S0223523420310655?via%3Dihub